EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance

Idrisa Rahman, Anju Meda iD, Kaitlyn A Moore iD, Payal Srivastava iD, Anika Dasgupta, Andaleeb Sajid iD, Suresh V Ambudkar iD, Huang-Chiao Huang iD

Photochemistry and Photobiology · 2026-03 · 102 (2) · 328-350

DOI: 10.1111/php.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Photochemistry and Photobiology, online erschienen am 14.11.2025. Verfasst von Idrisa Rahman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA. Hauptthemen laut MEDLINE: Photosensitizing Agents, Drug Resistance, Multiple, Photochemotherapy, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Science Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P‐glycoprotein (P‐gp, ABCB1)‐mediated multidrug resistance (MDR) remains a significant barrier to successful chemotherapy outcomes for cancer patients. While photoactivation of verteporfin (VP), a photosensitizer, has demonstrated success for overcoming MDR through direct protein aggregation upon photoactivation and through adenosine triphosphate (ATP) depletion, the impact of VP's formulation on P‐gp function and cellular energetics has not been fully characterized in this context. In this study, we screened four well‐established VP formulations—liposomal VP (L‐VP), lysophosphatidylcholine‐conjugated VP (lysoPC VP), liposomal formulation of lysoPC VP (L‐lysoPC VP), and a self‐assembled VP nanoaggregate (NanoVP), with a free form of VP as a control—for their ability to inhibit P‐gp. Using a combination of in vitro intracellular VP accumulation assays, P‐gp substrate retention experiments, and Seahorse‐based metabolic profiling, we identified NanoVP as the lead formulation for P‐gp modulation in cancer cells. NanoVP effectively depleted ATP in drug‐resistant cancer cells, while being recognized as a P‐gp substrate. Photodynamic priming with NanoVP at sub‐cytotoxic light doses enhanced P‐gp substrate retention within the cells without damaging P‐gp protein, indicating ATP depletion as the primary mode of functional inhibition. These findings highlighted NanoVP's clinical potential to enhance chemotherapeutic efficacy via photoactivation‐based modulation of P‐gp's function in multidrug‐resistant cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsDrug Resistance, MultiplePhotochemotherapyATP Binding Cassette Transporter, Subfamily B, Member 1Drug Resistance, NeoplasmNanoparticlesHumansVerteporfinCell Line, TumorAdenosine TriphosphateLiposomes

Stichwörter der Autor:innen

ABC transporterP‐glycoproteincellular ATP levelsdrug deliverymultidrug resistancephotodynamic priming

Substanzen

Photosensitizing AgentsATP Binding Cassette Transporter, Subfamily B, Member 1VerteporfinAdenosine TriphosphateLiposomes

Autor:innen und Institutionen

  • Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Anju Meda, Kaitlyn A Moore, Payal Srivastava, Andaleeb Sajid, Suresh V Ambudkar, Huang-Chiao Huang

Förderung

  • NIH HHS
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Rahman, I., Meda, A., Moore, K. A., Srivastava, P., Dasgupta, A., Sajid, A., Ambudkar, S. V., & Huang, H. C. (2026). Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance. Photochemistry and Photobiology, 102(2), 328-350. https://doi.org/10.1111/php.70049

Vancouver

Rahman I, Meda A, Moore KA, Srivastava P, Dasgupta A, Sajid A, et al. Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance. Photochemistry and Photobiology. 2026;102(2):328-350. doi:10.1111/php.70049

BibTeX
@article{Rahman2026,
  author = {Rahman, Idrisa and Meda, Anju and Moore, Kaitlyn A and Srivastava, Payal and Dasgupta, Anika and Sajid, Andaleeb and Ambudkar, Suresh V and Huang, Huang-Chiao},
  title = {Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance},
  journal = {Photochemistry and Photobiology},
  year = {2026},
  volume = {102},
  number = {2},
  pages = {328--350},
  doi = {10.1111/php.70049}
}
Kostenlos starten →